GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 767 filers reported holding GLAXOSMITHKLINE PLC in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $500,000 | -0.6% | 11,604 | 0.0% | 0.01% | -22.2% |
| Q2 2016 | $503,000 | +6.8% | 11,604 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $471,000 | -80.2% | 11,604 | -80.4% | 0.01% | -78.6% |
| Q4 2015 | $2,383,000 | +4.9% | 59,054 | 0.0% | 0.04% | +7.7% |
| Q3 2015 | $2,271,000 | -7.7% | 59,054 | 0.0% | 0.04% | +8.3% |
| Q2 2015 | $2,460,000 | -9.7% | 59,054 | 0.0% | 0.04% | -12.2% |
| Q1 2015 | $2,725,000 | +8.0% | 59,054 | 0.0% | 0.04% | +7.9% |
| Q4 2014 | $2,524,000 | -7.0% | 59,054 | 0.0% | 0.04% | -7.3% |
| Q3 2014 | $2,715,000 | -14.0% | 59,054 | 0.0% | 0.04% | -16.3% |
| Q2 2014 | $3,158,000 | +0.1% | 59,054 | 0.0% | 0.05% | -7.5% |
| Q1 2014 | $3,155,000 | +0.1% | 59,054 | 0.0% | 0.05% | +3.9% |
| Q4 2013 | $3,153,000 | +6.4% | 59,054 | 0.0% | 0.05% | 0.0% |
| Q3 2013 | $2,963,000 | +0.4% | 59,054 | 0.0% | 0.05% | -3.8% |
| Q2 2013 | $2,951,000 | – | 59,054 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
| KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
| Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
| Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
| Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
| PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
| P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
| EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
| Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |